Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
Udaya S Tantry,1 Karsten Schror,2 Eliano Pio Navarese,3 Young-Hoon Jeong,4 Jacek Kubica,3 Kevin P Bliden,1 Paul A Gurbel1 1Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, MD, USA; 2Department of Pharmacology and Clinical Pharmacol...
Saved in:
Main Authors: | Tantry US (Author), Schror K (Author), Navarese EP (Author), Jeong YH (Author), Kubica J (Author), Bliden KP (Author), Gurbel PA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017) -
Antithrombotic therapy in chronic liver disease: to clot or not to clot
by: Peter Calvert, et al.
Published: (2021) -
Clindamycin: An adjunct option in drug-resistant staphylococcal infections
by: Saloni Garg, et al.
Published: (2022) -
Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
by: Mario Enrico Canonico, et al.
Published: (2022) -
Adjunctive Low-Dose Aspirin plus Omega-3 Fatty Acid versus Low-Dose Doxycycline on Chronic Periodontitis
by: Shirin Zahra Farhad, et al.
Published: (2014)